AC Immune & Lilly Team Up Again to Stop Alzheimer’s with Brain-Targeting Drugs

AC Immune updates Eli Lilly deal to develop pill-based Tau drugs for Alzheimer’s, aiming to stop disease early with promising preclinical results.